T1	CHEM 4 16	Metronidazol
#1	AnnotatorNotes T1	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T2	DISO 24 49	agrandamientos gingivales
#2	AnnotatorNotes T2	C0376480; Gingival Overgrowth; Finding
T3	CHEM 64 78	Ciclosporina A
#3	AnnotatorNotes T3	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T4	PROC 891 899	tratados
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 97 119	agrandamiento gingival
#5	AnnotatorNotes T5	C0376480; Gingival Overgrowth; Finding
T6	DISO 121 123	AG
#6	AnnotatorNotes T6	C0376480; Gingival Overgrowth; Finding
T7	CHEM 138 146	fármacos
#7	AnnotatorNotes T7	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T8	DISO 267 269	AG
#8	AnnotatorNotes T8	C0376480; Gingival Overgrowth; Finding
T9	PROC 275 287	tratamientos
#9	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	PROC 351 393	estudio aleatorio controlado a doble ciego
#10	AnnotatorNotes T10	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T11	PROC 424 435	tratamiento
#11	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 505 507	AG
#12	AnnotatorNotes T12	C0376480; Gingival Overgrowth; Finding
T13	CHEM 532 546	ciclosporina A
#13	AnnotatorNotes T13	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T14	PROC 568 589	trasplantados renales
#14	AnnotatorNotes T14	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T15	ANAT 582 589	renales
#15	AnnotatorNotes T15	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T16	PROC 594 617	valoración cuantitativa
T17	DISO 622 624	AG
#16	AnnotatorNotes T17	C0376480; Gingival Overgrowth; Finding
T18	PROC 672 698	Análisis Digital de Imagen
#17	AnnotatorNotes T18	C2348290; Digital Image Analysis; Diagnostic Procedure
T19	DISO 803 805	AG
#18	AnnotatorNotes T19	C0376480; Gingival Overgrowth; Finding
T20	DISO 844 846	AG
#19	AnnotatorNotes T20	C0376480; Gingival Overgrowth; Finding
T21	CHEM 904 916	metronidazol
#20	AnnotatorNotes T21	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T22	CHEM 1280 1283	MNZ
#21	AnnotatorNotes T22	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T23	PROC 967 974	placebo
#22	AnnotatorNotes T23	C0032042; Placebos; Therapeutic or Preventive Procedure
T24	DISO 1035 1037	AG
#23	AnnotatorNotes T24	C0376480; Gingival Overgrowth; Finding
T25	PROC 1114 1121	placebo
#24	AnnotatorNotes T25	C0032042; Placebos; Therapeutic or Preventive Procedure
T26	DISO 1228 1230	AG
#25	AnnotatorNotes T26	C0376480; Gingival Overgrowth; Finding
T27	PROC 1335 1342	placebo
#26	AnnotatorNotes T27	C0032042; Placebos; Therapeutic or Preventive Procedure
T28	DISO 1401 1403	AG
#27	AnnotatorNotes T28	C0376480; Gingival Overgrowth; Finding
T29	PROC 1510 1517	placebo
#28	AnnotatorNotes T29	C0032042; Placebos; Therapeutic or Preventive Procedure
T30	PROC 1603 1610	placebo
#29	AnnotatorNotes T30	C0032042; Placebos; Therapeutic or Preventive Procedure
T31	DISO 1731 1733	AG
#30	AnnotatorNotes T31	C0376480; Gingival Overgrowth; Finding
T32	PROC 1774 1781	placebo
#31	AnnotatorNotes T32	C0032042; Placebos; Therapeutic or Preventive Procedure
T33	PROC 1880 1891	tratamiento
#32	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	DISO 1967 1992	agrandamientos gingivales
#33	AnnotatorNotes T34	C0376480; Gingival Overgrowth; Finding
T35	CHEM 2008 2011	CsA
#34	AnnotatorNotes T35	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T36	DISO 2065 2067	AG
#35	AnnotatorNotes T36	C0376480; Gingival Overgrowth; Finding
T37	DISO 2096 2121	sobreinfección bacteriana
#36	AnnotatorNotes T37	C1868758; Superinfection bacterial; Disease or Syndrome
T38	DISO 2127 2147	inflamación gingival
#37	AnnotatorNotes T38	C0017574; Gingivitis; Disease or Syndrome
T39	ANAT 39 49	gingivales
#38	AnnotatorNotes T39	C0017562; Gingiva; Tissue | C1278912; Entire gingiva; Body Part, Organ, or Organ Component
T40	ANAT 111 119	gingival
#39	AnnotatorNotes T40	C0017562; Gingiva; Tissue | C1278912; Entire gingiva; Body Part, Organ, or Organ Component
T41	CHEM 308 320	antibióticos
#40	AnnotatorNotes T41	C0003232; Antibiotics; Antibiotic
T42	CHEM 440 452	metronidazol
#41	AnnotatorNotes T42	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T43	CHEM 924 927	MNZ
#42	AnnotatorNotes T43	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T44	CHEM 1755 1758	MNZ
#43	AnnotatorNotes T44	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T45	CHEM 1050 1053	MNZ
#44	AnnotatorNotes T45	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T46	CHEM 1584 1587	MNZ
#45	AnnotatorNotes T46	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T47	CHEM 1896 1908	metronidazol
#46	AnnotatorNotes T47	C0025872; metronidazole; Organic Chemical · Pharmacologic Substance
T48	ANAT 1982 1992	gingivales
#47	AnnotatorNotes T48	C0017562; Gingiva; Tissue | C1278912; Entire gingiva; Body Part, Organ, or Organ Component
T49	ANAT 2139 2147	gingival
#48	AnnotatorNotes T49	C0017562; Gingiva; Tissue | C1278912; Entire gingiva; Body Part, Organ, or Organ Component
T50	LIVB 195 209	periodoncistas
#49	AnnotatorNotes T50	C0260115; Periodontists; Professional or Occupational Group
T51	Duration 461 471	siete días
T52	Dose 473 479	250 mg
T53	Frequency 480 494	3 veces al día
T55	LIVB 550 567	pacientes adultos
#50	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T57	Neg_cue 716 723	ninguno
T58	LIVB 734 743	pacientes
#51	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 881 890	pacientes
#52	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Duration 1001 1008	30 días
T62	LIVB 1092 1101	pacientes
#53	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T64	LIVB 1260 1269	pacientes
#54	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T66	LIVB 1701 1710	pacientes
#55	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	Duration 1917 1927	siete días
T71	LIVB 2111 2121	bacteriana
#56	AnnotatorNotes T71	C0004611; Bacteria; Bacterium
T54	LIVB 950 959	controles
#57	AnnotatorNotes T54	C0009932; Control Groups; Group
A1	Population_data T55 Age
A2	Assertion T58 Negated
T56	Quantifier_or_Qualifier 1186 1216	estadísticamente significativo
A3	Assertion T56 Negated
#58	AnnotatorNotes T56	C0237881; Statistical Significance; Quantitative Concept
T61	Neg_cue 1169 1172	sin
R1	Negation Arg1:T61 Arg2:T56	
T63	CONC 1060 1068	modificó
A4	Assertion T63 Negated
T65	Neg_cue 1054 1056	no
R2	Negation Arg1:T65 Arg2:T63	
T68	CONC 1373 1384	diferencias
A5	Assertion T68 Negated
#59	AnnotatorNotes T68	C1705241; Delta (difference); Quantitative Concept
T69	Neg_cue 1359 1361	no
R3	Negation Arg1:T69 Arg2:T68	
T70	Neg_cue 1928 1930	no
T72	Observation 1941 1959	regresión completa
A6	Assertion T72 Negated
R4	Negation Arg1:T70 Arg2:T72	
T74	Spec_cue 2069 2081	posiblemente
T75	CONC 2085 2092	reducir
A8	Assertion T75 Speculated
#60	AnnotatorNotes T75	C0392756; Reduced; Qualitative Concept (?)
R7	Causes Arg1:T3 Arg2:T2	
R8	Negation Arg1:T57 Arg2:T58	
T76	Observation 781 798	remisión completa
A9	Assertion T76 Negated
#61	AnnotatorNotes T76	C0677874; In complete remission; Finding
R9	Negation Arg1:T57 Arg2:T76	
R10	Experiences Arg1:T58 Arg2:T76	
#62	AnnotatorNotes T72	C0677874; In complete remission; Finding
R5	Location_of Arg1:T39 Arg2:T2	
R11	Location_of Arg1:T40 Arg2:T5	
R12	Location_of Arg1:T40 Arg2:T6	
R13	Causes Arg1:T7 Arg2:T5	
R14	Causes Arg1:T7 Arg2:T6	
T73	Observation 232 262	remisiones parciales o totales
#63	AnnotatorNotes T73	C1521726; partial response; Finding | C0677874; In complete remission; Finding
R15	Before Arg1:T8 Arg2:T73	
R16	After Arg1:T73 Arg2:T9	
R17	Used_for Arg1:T41 Arg2:T9	
T77	Duration 288 294	cortos
R18	Has_Duration_or_Interval Arg1:T41 Arg2:T77	
T78	Observation 413 419	efecto
#64	AnnotatorNotes T78	C1518681; Outcome of Therapy; Finding (?)
R19	Causes Arg1:T11 Arg2:T78	
R20	Used_for Arg1:T42 Arg2:T11	
R21	Has_Duration_or_Interval Arg1:T42 Arg2:T51	
R22	Has_Dose_or_Strength Arg1:T42 Arg2:T52	
R23	Has_Frequency Arg1:T42 Arg2:T53	
R25	Causes Arg1:T13 Arg2:T12	
T79	Quantifier_or_Qualifier 508 518	incipiente
#65	AnnotatorNotes T79	C0205256; Incipient; Temporal Concept
R26	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T79	
R27	Experiences Arg1:T55 Arg2:T78	
R28	Experiences Arg1:T55 Arg2:T14	
R29	Location_of Arg1:T15 Arg2:T14	
R30	Experiences Arg1:T55 Arg2:T13	
R31	Experiences Arg1:T55 Arg2:T12	
R32	Experiences Arg1:T55 Arg2:T11	
T80	Quantifier_or_Qualifier 636 655	semiautomáticamente
R42	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T80	
R43	Before Arg1:T19 Arg2:T76	
R44	Experiences Arg1:T58 Arg2:T19	
T81	PROC 822 829	estudio
#66	AnnotatorNotes T81	C0681814; research study; Research Activity
R45	After Arg1:T76 Arg2:T81	
T82	CONC 858 869	tiempo cero
R46	Experiences Arg1:T59 Arg2:T20	
R47	Experiences Arg1:T59 Arg2:T4	
R49	Used_for Arg1:T21 Arg2:T4	
R50	Used_for Arg1:T43 Arg2:T4	
R51	Experiences Arg1:T54 Arg2:T23	
T83	CONC 1012 1021	evolución
#67	AnnotatorNotes T83	C0449259; Clinical course; Temporal Concept (?)
R54	Has_Duration_or_Interval Arg1:T83 Arg2:T60	
R58	Experiences Arg1:T62 Arg2:T25	
R60	Experiences Arg1:T64 Arg2:T26	
R62	Experiences Arg1:T64 Arg2:T22	
R63	Experiences Arg1:T64 Arg2:T27	
T84	CONC 1122 1135	se incrementó
#68	AnnotatorNotes T84	C0205217; Increased; Quantitative Concept
R65	Overlap Arg1:T84 Arg2:T60	
T86	CONC 834 846	índice de AG
R67	Overlap Arg1:T86 Arg2:T82	
T87	CONC 1025 1037	índice de AG
T88	CONC 1221 1230	índice AG
T89	CONC 1391 1403	índice de AG
T90	CONC 1427 1447	principio del ensayo
#70	AnnotatorNotes T90	C4684789; Study Start; Temporal Concept
R68	Overlap Arg1:T68 Arg2:T90	
R69	Overlap Arg1:T89 Arg2:T90	
T91	CONC 1451 1460	finalizar
#71	AnnotatorNotes T91	C2983670; Study End Date; Temporal Concept
R71	Overlap Arg1:T89 Arg2:T91	
T92	CONC 1494 1497	lAG
#72	AnnotatorNotes T92	[Índice de a gingival, 'Gingival Bleeding Index']
R72	Overlap Arg1:T92 Arg2:T91	
T93	CONC 1630 1642	t de Student
#73	AnnotatorNotes T93	C0871453; Students T Test; Intellectual Product
T94	Quantifier_or_Qualifier 1734 1753	clínico grado 1 ó 2
R73	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T94	
R74	Experiences Arg1:T66 Arg2:T31	
T95	CONC 1795 1807	t de Student
#74	AnnotatorNotes T95	C0871453; Students T Test; Intellectual Product
R77	Experiences Arg1:T66 Arg2:T32	
R78	Experiences Arg1:T66 Arg2:T44	
R79	Experiences Arg1:T66 Arg2:T30	
R80	Experiences Arg1:T66 Arg2:T46	
R81	Experiences Arg1:T66 Arg2:T29	
R75	Used_for Arg1:T47 Arg2:T33	
R82	Has_Duration_or_Interval Arg1:T47 Arg2:T67	
R84	Before Arg1:T33 Arg2:T72	
R85	Location_of Arg1:T48 Arg2:T34	
R87	Causes Arg1:T35 Arg2:T34	
T97	CONC 2047 2060	curso clínico
#76	AnnotatorNotes T97	C0449259; Clinical course; Temporal Concept (?)
R88	Speculation Arg1:T74 Arg2:T75	
R89	Causes Arg1:T71 Arg2:T37	
R90	Location_of Arg1:T49 Arg2:T38	
R91	Overlap Arg1:T34 Arg2:T37	
R92	Overlap Arg1:T34 Arg2:T38	
R93	Overlap Arg1:T36 Arg2:T37	
R94	Overlap Arg1:T36 Arg2:T38	
R6	Overlap Arg1:T87 Arg2:T60	
#69	AnnotatorNotes T63	C1705241; Delta (difference); Quantitative Concept
R24	Overlap Arg1:T63 Arg2:T60	
R33	Has_Quantifier_or_Qualifier Arg1:T84 Arg2:T56	
A7	Experiencer T50 Other
A10	Experiencer T55 Patient
A11	Experiencer T58 Patient
A12	Experiencer T59 Patient
A13	Experiencer T54 Patient
A14	Experiencer T62 Patient
A15	Experiencer T64 Patient
A16	Experiencer T66 Patient
